STOCKHOLM, July 1, 2024 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held from June 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference has become a cornerstone event for medical and health professionals worldwide, fostering collaboration and showcasing cutting-edge research in dermatology, rheumatology, and related fields.

Under the theme "Uncovering the Broad Spectrum of Psoriatic Disease," this year's conference aimed to foster international collaboration on research, advocacy initiatives, and awareness among medical professionals and industry stakeholders.

Delegates from over 76 countries convened at the IFPA Conference 2024, representing a diverse array of clinical experts, health professionals, and patient organizations. Accredited by the European Accreditation Council for Continuing Medical Education (EACCME), the conference featured over 190 abstracts covering pivotal topics such as biomarkers, imaging, and comorbidities.

Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

A highlight of the conference was the recognition of exceptional e-posters through the Poster Prize. The event also showcased over 50 high-level presentations, spotlighting cutting-edge research and advancements in the field of psoriatic disease.

Professor April Armstrong, Conference President, remarked on the conference's impact: "We shared knowledge, engaged in meaningful conversations, and highlighted significant achievements in the prevention, diagnosis, and treatment of psoriatic disease. The IFPA conference serves as a platform to focus on future research and advance care for all persons living with psoriatic disease."

Ingvar